Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Stages of Alzheimer’s Disease

Embed Size (px)

Citation preview

  • 8/12/2019 Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Sta

    1/10

  • 8/12/2019 Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Sta

    2/10

  • 8/12/2019 Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Sta

    3/10

  • 8/12/2019 Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Sta

    4/10

  • 8/12/2019 Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Sta

    5/10

  • 8/12/2019 Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Sta

    6/10

  • 8/12/2019 Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Sta

    7/10

  • 8/12/2019 Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Sta

    8/10

  • 8/12/2019 Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Sta

    9/10

  • 8/12/2019 Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Sta

    10/10

    http://www.forestclinicaltrials.com/CTR/CTRController/CTRViewPdf?_file_id=scsr/SCSR_MEM-MD-22_final.pdfhttp://www.forestclinicaltrials.com/CTR/CTRController/CTRViewPdf?_file_id=scsr/SCSR_MEM-MD-22_final.pdfhttp://www.forestclinicaltrials.com/CTR/CTRController/CTRViewPdf?_file_id=scsr/SCSR_MEM-MD-22_final.pdfhttp://guidance.nice.org.uk/TA/WaveR111/1/Consultation/EvaluationReport/ManufacturerSubmissions/LundbeckUK/pdf/Englishhttp://guidance.nice.org.uk/TA/WaveR111/1/Consultation/EvaluationReport/ManufacturerSubmissions/LundbeckUK/pdf/Englishhttp://guidance.nice.org.uk/TA/WaveR111/1/Consultation/EvaluationReport/ManufacturerSubmissions/LundbeckUK/pdf/Englishhttp://www.cochrane-net.org/openlearning/html/mod13-5.htmhttp://www.cochrane-net.org/openlearning/html/mod13-5.htmhttp://guidance.nice.org.uk/TA/WaveR111/1/Consultation/DraftGuidancehttp://guidance.nice.org.uk/TA/WaveR111/1/Consultation/DraftGuidancehttp://wwwlundbecktrialscom/Data/PDFs/10116_Final_11Oct2006_CTRSpdfhttp://wwwlundbecktrialscom/Data/PDFs/10116_Final_11Oct2006_CTRSpdfhttp://guidance.nice.org.uk/TA/WaveR111/1/AssessmentReporthttp://guidance.nice.org.uk/TA/WaveR111/1/AssessmentReporthttps://www.iqwig.de/download/A05-19C_Abschlussbericht_Memantin_bei_Alzheimer_Demenz.pdfhttps://www.iqwig.de/download/A05-19C_Abschlussbericht_Memantin_bei_Alzheimer_Demenz.pdfhttps://www.iqwig.de/download/A05-19C_Abschlussbericht_Memantin_bei_Alzheimer_Demenz.pdf